Category Press Releases

May 15, 2015 04:06 PM
Pennsylvania-based Hotel Group -- Neema Hospitality -- To Support ABC2 For Second Year In A Row

BethAnn Telford, a brain cancer survivor and Ironman athlete, is the inspiration behind the company’s summer hotel promotion.

April 15, 2015 10:01 AM
Meet Kathleen Norton: ABC2's Vice President of Strategic Partnerships

We welcome the newest member of our team. Kathleen brings a wealth of major and corporate gift development experience.

March 19, 2015 09:35 PM
The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers

Proceeds from the Florida Brain Cancer 5k support this ongoing partnership.

December 4, 2014 02:02 PM
David Cook and Fans Reach $1 Million Fundraising Mark for Brain Cancer Research at Benefit Concert

Concert proceeds benefit Accelerate Brain Cancer Cure.

November 6, 2014 02:51 PM
Brain Tumor Community Pushes for Inclusion of Patient-Focused Endpoints In Future Clinical Trials

Second Brain Tumor Clinical Trial Endpoints Workshop identified steps needed to include measures of patient signs, symptoms, and function as part of evaluation of therapy benefit.

October 14, 2014 12:50 PM
San Diego Brain Cancer Experts Partner with Industry on Research for Early Tumor Recurrence Detection

ABC2 funds project between UC San Diego Health System and Regulus Therapeutics Inc.

September 30, 2014 12:43 PM
San Diego Residents Rally Around 40-Story Rappel for Brain Cancer Research

On October 31st and November 1st, 2014, brave participants fighting to end brain cancer will rappel 365 ft. and go Over the Edge for Brain Cancer (@OTE4BrainCancer).

May 27, 2014 11:22 AM
Pennsylvania-Based Hotel Group - Neema Hospitality - To Support Accelerate Brain Cancer Cure

BethAnn Telford, a brain cancer survivor and Ironman athlete, is the inspiration behind the summer hotel promotion.

December 23, 2013 11:14 AM
ABC2-Funded Research on Glioma Genomics Featured in Science

Recurrent Brain Cancers Follow Distinctive Genetic Paths, UCSF Team Shows Commonly Used Brain Tumor Chemotherapy Agent May Propel Recurrent Tumors to Malignancy

Pages

Share |

Join us in our fight for a cure!

Twitter